Fig. 7From: Engineering M1-derived nanovesicles loading with docosahexaenoic acid synergizes ferroptosis and immune activation for treating hepatocellular carcinomaAnalysis of immune cell subsets from the tumor tissues with different treatments for 12Â days. A Immunohistochemistry images of the expression of GPX4. (B-C) Flow cytometric analysis of M1 (F4/80+CD86+), M2 (F4/80+CD206+) and CD8+T cellsBack to article page